Presentations Medicenna Therapeutics Corp. - Corporate Presentation Q4 November 2020 Upcoming Events December 1 - December 3, 2020 Piper Sandler 32nd Annual Virtual Healthcare Conference Go to December 1 - December 3, 2020 Evercore ISI 3rd Annual HealthCONx Conference Go to Past Events June 9 - June 12, 2020 Spring Virtual Investor Summit (Virtual) Go to May 29 - May 31, 2020 In vitro and in vivo characteristics of MDNA11: A long-acting 'Beta-only' IL-2 Superkine in syngeneic mice tumor models and non-human primates Go to May 29 - May 31, 2020 MDNA55 survival in recurrent glioblastoma ("rGBM") patients expressing the interleukin-4 receptor ("IL4R") as compared to a matched synthetic control Go to March 26 - March 27, 2020 6th Annual Immuno-Oncology Innovation Forum (Virtual) Go to March 25, 2020 at 10:00 AM EDT IL-2 Superkine, MDNA19, Non-Human Primate Study Go to January 17 - January 19, 2020 AlphaNorth Capital Investment Conference Go to Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Page 4 Next page next › Last page last »
May 29 - May 31, 2020 In vitro and in vivo characteristics of MDNA11: A long-acting 'Beta-only' IL-2 Superkine in syngeneic mice tumor models and non-human primates Go to
May 29 - May 31, 2020 MDNA55 survival in recurrent glioblastoma ("rGBM") patients expressing the interleukin-4 receptor ("IL4R") as compared to a matched synthetic control Go to
